Keasling Biomanufacturing ApS: Financial statements 2024
CVR: 43607774
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Keasling Biomanufacturing ApS (CVR 43607774) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -25,058 and a net result of DKK -23,957. Equity in the 2024 report amounted to DKK 47,141. The solvency ratio was 44.9%.
- Gross Profit
- DKK -25,058
- Profit/Loss
- DKK -23,957
- Equity
- DKK 47,141
- Total Assets
- DKK 105,091
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Keasling Biomanufacturing ApS has published its interim report for the period October 27, 2022 to December 31, 2023.
As of November 7, 2024, Jay D Keasling is registered as adm. dir. of Keasling Biomanufacturing ApS.
As of November 7, 2024, Ole Larsen has stepped down as liquidator of Keasling Biomanufacturing ApS.
On November 7, 2024, Keasling Biomanufacturing ApS exited liquidation.
As of September 6, 2024, Ole Larsen is registered as liquidator of Keasling Biomanufacturing ApS.
On September 6, 2024, Keasling Biomanufacturing ApS entered liquidation.
As of August 23, 2024, Jay D Keasling has stepped down as director of Keasling Biomanufacturing ApS.
About Keasling Biomanufacturing ApS
Keasling Biomanufacturing ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jay D Keasling. The company is owned by The Jay D. Keasling Trust. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -9,942 and a net result of DKK -11,228 compared with DKK -23,957 the year before. Equity in the 2025 report amounted to DKK 35,914.